Загрузка...
Dynamic RMST curves for survival analysis in clinical trials
BACKGROUND: The data from immuno-oncology (IO) therapy trials often show delayed effects, cure rate, crossing hazards, or some mixture of these phenomena. Thus, the proportional hazards (PH) assumption is often violated such that the commonly used log-rank test can be very underpowered. In these tri...
Сохранить в:
| Опубликовано в: : | BMC Med Res Methodol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7534804/ https://ncbi.nlm.nih.gov/pubmed/32854619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12874-020-01098-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|